Chemomab
Chemomab is a clinical-stage biotech company discovering and developing innovative therapeutics for conditions that involve Inflammation and fibrosis.
In crafting Chemomab’s brand, the central challenge was finding a balance — between the complexity of cutting-edge biological research, and the simplicity of its promise; between the hardship of living with fibrotic disease, and the knowledge that help is on the way.
